Overview

177Lu-labeled NY108 SPECT Imaging in Patients

Status:
Recruiting
Trial end date:
2024-12-12
Target enrollment:
Participant gender:
Summary
This is a single arm study to evaluate the safety and biodistribution of 177Lu-labeled NY108 (177Lu-NY108) SPECT Imaging in patients.
Phase:
Early Phase 1
Details
Lead Sponsor:
Affiliated Hospital of Jiangnan University